Crossref
Once-weekly HIV pill performs as well as daily treatment in phase III study
Pharmaceutical Journal · 2026
DOI: 10.1211/pj.2026.1.422349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Journal, 2026.
Abstract (Originalsprache)
A once-weekly tablet could maintain HIV control as well as existing daily treatment, according to the results of a phase III international study. The study’s findings were published in the New England Journal of Medicine on 29 July 2026 and presented at the AIDS 2026 conference, held in Rio de Janeiro, Brazil, on 26–31 July […]
Zitieren
APA
(2026). Once-weekly HIV pill performs as well as daily treatment in phase III study. Pharmaceutical Journal. https://doi.org/10.1211/pj.2026.1.422349
Vancouver
Once-weekly HIV pill performs as well as daily treatment in phase III study. Pharmaceutical Journal. 2026. doi:10.1211/pj.2026.1.422349
BibTeX
@article{euvimed2026,
title = {Once-weekly HIV pill performs as well as daily treatment in phase III study},
journal = {Pharmaceutical Journal},
year = {2026},
doi = {10.1211/pj.2026.1.422349}
}
EUVIMED